Bioengineering and Biotechnology: An Asia-Pacific Perspective
The world’s highest priority in the 21st century is healthcare. In economically developed Asian-Pacific societies, there is a well-established perception that improvements in healthcare and quality of life depend on advancements in bioengineering and biotechnology.
Many countries in the Asia-Pacific region have strong human resources, rich clinical expertise and, of course, a large population – all valuable for translational medical research. By the second half of the 21st century, countries such as China and India, with their large populations, will also have a high percentage of aged individuals. Therefore, bioengineering and biotechnology developments directly related to medical care, healthcare, and welfare are considered crucial. In addition to demands placed by globalization on the development of medical technologies, there are also increasing expectations for the creation of new bioengineering and biotechnology products stemming from breakthroughs in life sciences.
KeywordsAsia Pacific Economic Cooperation Clinical Engineering Clinical Engineer Singapore Government Translational Medical Research
- 1.Makoto Kikuchi, “Present State of Biomedical Measurement Technologies and Future Prospects,” AIST TODAY, English version, pp. 4–7, 2007Google Scholar
- 2.Toshio Tamura, (guest editor), “Recent Technological Developments in Japan,” IEEE EMB Magazine, Vol. 24, No.4, 2005Google Scholar
- 3.Japan Association for Clinical Engineering Technologists; www.jacet.or.jp.
- 5.Singapore’s National Research Foundation; www.nrf.gov.sg/.
- 6.Biotechnology in Singapore. Goh R, Biotechnology Team, Western Australian Department of Industry and Resources, February 2005; www.doir.wa.gov.au/documents/business andindustry/BIOTECHNOLOGY_IN_SINGAPORE.pdf.
- 7.National University of Singapore; www.nus.edu.sg/.
- 8.Nanyang Technological University; www.ntu.edu.sg/.